RK STRATEGIES, INC.

Lobbying for CLEARMIND MEDICINE, INC · Developer of Psychedelics Medicines

Filing Registration

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 16, 2025

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

British Columbia

Lobbying activity 3

Veterans

Issues Surrounding Psychedelic Medicines

Health Issues

Issues Surrounding Psychedelic Medicines

Defense

Issues Surrounding Psychedelic Medicines

Foreign interests disclosed 1

Section 7 of the LD-2: foreign entities that own part of the client, paid toward this lobbying, or stand to benefit from it.

CLEARMIND MEDICINE, INC.

Israel · Tel Aviv · owns 100% of the client · contributed $10,000.00

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.